Blog

Follow us for the latest trends, insights and
innovations in the pharmaceutical industry.
Pharmaceutical intermediate quality control banner: COA pass vs lab fail risk analysis for incoming QC inspection after raw‑material arrival

Incoming QC: 3 Checks That Stop Bad Batches on Arrival

A supplier COA is a declaration, not proof. Run incoming QC on arrival: seven checks that decide whether to release or reject a batch.
Read More →
Blog cover:5 Costly RFQ Mistakes, Better Quotes Start with a Clear Inquiry, Pharmaceutical Intermediate Sourcing workflow diagram

5 Costly RFQ Mistakes That Inflate Your Intermediate Quote

A vague request for quotation invites an inflated, inaccurate intermediate quote. This buyer's guide shows the five costly RFQ mistakes that drive prices up and ...
Read More →
Blog cover: Who Calibrated Your Supplier's HPLC? 7 Hidden COA Risks. HPLC calibration, reference standard traceability and COA quality risk analysis for pharmaceutical raw‑material buyers.

Who Calibrated Your Supplier’s HPLC? 7 Costly Hidden Risks

Every assay value on a COA is measured against a reference standard — if that standard is weak, every number built on it is weak. ...
Read More →
Blog cover for specification setting for chemical intermediates, 7 costly mistakes pharmaceutical buyers make when reviewing supplier specifications

7 Costly Mistakes to Avoid in Intermediate Specifications

This buyer's guide explains how specification limits are set, how to judge whether they are reasonable, and the seven costly mistakes buyers make when they ...
Read More →
Scroll to Top

Contact us to Get the Best Product Solution